View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026

Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES10 MARCH 2026 at 13.50 EET          Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 In accordance with a decision by the Board of Directors, Orion Corporation has on 10 March 2026 transferred altogether 172,778 Orion Corporation B shares held by the company as a share reward for earning period 2023–2025 and a reward for commitment part to the persons belonging to the Share-based Incentive Plan of Orion Group. The transfer i...

 PRESS RELEASE

Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026

Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026 ORION OYJ        PÖRSSITIEDOTE – MUUTOKSET OMIEN OSAKKEIDEN OMISTUKSESSA         10.3.2026 KLO 13.50          Orion Oyj: 172 778 oman B-osakkeen luovutus 10.3.2026 Orion Oyj:n hallituksen päätöksen mukaisesti Orion Oyj on 10.3.2026 luovuttanut yhteensä 172 778 kappaletta yhtiön hallussa olevaa Orion Oyj:n B-osaketta Orion-konsernin avainhenkilöiden kannustinjärjestelmään kuuluville henkilöille ansaintajaksolta 2023–2025 ja sitouttavan osakepalkkion osuutena maksettavana palkkiona. Luovutus perustuu yhtiökokouksen 23.3.2022 antamaan...

 PRESS RELEASE

Transactions in Connection with Share Buy-back Program

Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; March 9, 2026 – Genmab A/S (Nasdaq: GMAB). On February 17, 2026, Genmab announced the initiation of a share buy-back program to repurchase up to 342,130 shares with a maximum aggregate total value of DKK 725 million to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than March 31, 2026. The following transactions were executed under the program from March 2 to March 6, 2026:  No. of sharesAverage price (DKK)Tot...

 PRESS RELEASE

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS6 March 2026 at 16.00 EET          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly and indirectly by BlackRock, Inc. and its funds increased on 5 March 2026 above five (5) per cent of Orion C...

 PRESS RELEASE

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        6.3.2026 KLO 16.00          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan ja välillisesti omistamien Orionin osakkeiden osuus on 5.3.2026 ylittänyt viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRock, Inc.:n ja sen rahastojen osu...

Bayer AG: 1 director

A director at Bayer AG bought 2,671 shares at 37.431EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Fresenius SE & Co. KGaA: 1 director

A director at Fresenius SE & Co. KGaA bought 4,130 shares at 47.107EUR and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS5 MARCH 2026 at 15.00 EET          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly and indirectly by BlackRock, Inc. and its funds decreased on 4 March 2026 below five (5) per cent of Orion C...

 PRESS RELEASE

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ        PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE        5.3.2026 KLO 15.00          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan ja välillisesti omistamien Orionin osakkeiden osuus on 4.3.2026 alittanut viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. BlackRock, Inc.:n ja sen rahastojen osu...

Research Department
  • Research Department

INFORME DIARIO 05 MARZO + RDOS. EUROPA. PREVIEWS (ANÁLISIS BANCO SABAD...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: INDRA. EUROPA: BAYER, DHL GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Vuelta de números verdes Las bolsas europeas rebotaron por encima del +1,5% (el Ibex cerca del +3,0%) a pesar de que la guerra en Oriente Medio siguió generando in...

Michael B. Schäfer ... (+2)
  • Michael B. Schäfer
  • Stephan Wulf
Rafael Bonardell
  • Rafael Bonardell

BAYER: RDOS. 4T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'25 vs 4T'24: Ventas: 11.438 M euros (-2,5% vs -6,2% BS(e) y -3,3% consenso); EBITDA: 1.968 M euros (-16,2% vs -20,8% BS(e) y -18,7% consenso). Rdos. 2025 vs 2024: Ventas: 45.575 M euros (-2,2% vs -3,2% BS(e) y -2,4% consenso); EBITDA: 9.669 M euros (-4,5% vs -5,6% BS(e) y -5,1% consenso).

Research Department
  • Research Department

INFORME DIARIO 04 MARZO + RDOS. EUROPA. PREVIEWS (ANÁLISIS BANCO SABAD...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: REPSOL EUROPA: ADIDAS, BAYER, PROSUS Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Oleada de ventas donde sólo se salvó el crudo Jornada de fuertes caídas en la mayoría de los índices mundiales (algo más contenidas en EE.UU.), con el temor a ...

Delphine Brault ... (+6)
  • Delphine Brault
  • Emira Sagaama
  • Juan Ros-Padilla
  • Luis de Toledo Heras
  • Marc Lavaud
  • Nathan Mietlicki
Delphine Brault ... (+6)
  • Delphine Brault
  • Emira Sagaama
  • Juan Ros-Padilla
  • Luis de Toledo Heras
  • Marc Lavaud
  • Nathan Mietlicki
 PRESS RELEASE

Correction to Company Announcement No. 13 of March 2, 2026

Correction to Company Announcement No. 13 of March 2, 2026 Company Announcement COPENHAGEN, Denmark; March 2, 2026 – (Nasdaq: GMAB) - Correction: In Company Announcement no. 13/2026 regarding transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons it was reported that the share price associated with these transactions was DKK 0,00. The correct price is DKK 1,867.50. In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the tr...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch